Patents Assigned to Mi2 Holdings LLC
  • Publication number: 20220152251
    Abstract: A shipping container having photodynamic pathogen reduction properties. The shipping container include photosensitizers that when exposed to light actively and continuously disinfect their surfaces. Methods of adding or incorporating into or on to photosensitizers to a shipping container.
    Type: Application
    Filed: November 19, 2021
    Publication date: May 19, 2022
    Applicant: Mi2 Holdings LLC
    Inventors: Andrew Hopkins, Thomas Hopkins
  • Publication number: 20220154404
    Abstract: A shipping container having photodynamic pathogen reduction properties. The shipping container include photosensitizers that when exposed to light actively and continuously disinfect their surfaces. Methods of adding or incorporating into or on to photosensitizers to a shipping container.
    Type: Application
    Filed: November 19, 2021
    Publication date: May 19, 2022
    Applicant: Mi2 Holdings LLC
    Inventors: Andrew Hopkins, Thomas Hopkins, Mark Land
  • Publication number: 20220031887
    Abstract: A complex or composition of a photosensitizer associated with an inclusion complex former for use in forming active surfaces and active materials to kill or render inactive pathogens. A composition having photosensitizer associated with an inclusion complex former, a nanoparticle and liquid. Treating a material, such as a fabric, fiber, product, surface, woven, and non-woven with a photosensitizer and nanoparticle whereby treated material is an active surface that kills or renders inactive pathogens upon illumination with sufficient light.
    Type: Application
    Filed: May 12, 2021
    Publication date: February 3, 2022
    Applicant: Mi2 Holdings LLC
    Inventors: Andrew Hopkins, Thomas Hopkins, Mark Land
  • Publication number: 20210316011
    Abstract: A nanocomposition for use in treating cardiac, oncologic, bariatric, or dermatologic indications, conditions and diseases condition using phthalocyanine dye, such as IR700. A nanocomposition having IR700, an 8PEG nanoparticle and a RGD, or iRGD targeting agent. Administering a product comprising IR700 to a patient, whereby the IR700 is delivered to the target tissue, and found in only target tissue; and administering light to activate the IR700, thereby producing an ROS.
    Type: Application
    Filed: April 12, 2021
    Publication date: October 14, 2021
    Applicant: Mi2 Holdings LLC
    Inventors: Andrew Hopkins, Thomas Hopkins
  • Publication number: 20210299257
    Abstract: A nanocomposition for use in treating a pathogen condition using phthalocyanine dye, such as IR700. A nanocomposition having IR700, an 8PEG nanoparticle and a pathogen targeting peptide. Administering a product comprising IR700 to a patient, whereby the IR700 is delivered to pathogen tissue, and found in only pathogen tissue; and administering light to activate the IR700, thereby producing an ROS.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 30, 2021
    Applicant: Mi2 Holdings LLC
    Inventors: Andrew Hopkins, Thomas Hopkins